Purchases and Sales Made in Q2 2022 in Vertex Pharmaceuticals Inc (VRTX)
This table provides information about the institutional ownership of Vertex Pharmaceuticals Inc (VRTX) during Q2 2022. The information is specifically focused on institutions that hold shares of VERTEX PHARMACEUTICALS INC .
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 05, 2022
Q2 2022
|
Parnassus Investments, LLC
|
SELL
|
- |
-310K- 54.16% |
$72.7M - $90.5M
|
262K
$132M
|
|
|
Aug 12, 2022
Q2 2022
|
Apg Asset Management N.V.
Amsterdam, P7 |
SELL
|
- |
-337K- 29.09% |
$79.1M - $98.5M
|
820K
$412M
|
|
|
Aug 15, 2022
Q2 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-342K- 6.45% |
$80.4M - $100M
|
4.96M
$2.49B
|
|
|
Aug 15, 2022
Q2 2022
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-384K- 7.77% |
$90.3M - $112M
|
4.56M
$2.29B
|
|
|
Aug 15, 2022
Q2 2022
|
Epoch Investment Partners, Inc.
New York, NY |
SELL
|
- |
-411K- 45.01% |
$96.5M - $120M
|
502K
$252M
|
|
|
Jul 12, 2022
Q2 2022
|
Manning & Napier Group, LLC
|
SELL
|
- |
-415K- 59.7% |
$97.5M - $121M
|
280K
$141M
|
|
|
Aug 12, 2022
Q2 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-422K- 13.52% |
$99.1M - $123M
|
2.7M
$1.36B
|
|
|
May 14, 2024
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-437K- 29.45% |
$103M - $128M
|
1.05M
$526M
|
|
|
Aug 15, 2022
Q2 2022
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-466K- 62.55% |
$109M - $136M
|
279K
$140M
|
|
|
Jul 22, 2022
Q2 2022
|
Aaron Wealth Advisors LLC
|
SELL
|
- |
-589K- 99.61% |
$138M - $172M
|
2.33K
$1.17M
|
|
|
Aug 11, 2022
Q2 2022
|
Clearbridge Investments, LLC
New York, NY |
SELL
|
- |
-909K- 17.65% |
$214M - $266M
|
4.24M
$2.13B
|
|
|
Aug 15, 2022
Q2 2022
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-1.25M- 11.89% |
$295M - $367M
|
9.3M
$4.67B
|
|
|
Aug 05, 2022
Q2 2022
|
Loomis Sayles & CO L P
|
SELL
|
- |
-1.93M- 30.23% |
$454M - $565M
|
4.46M
$2.24B
|